BPC-157 10mg

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protective protein found in human gastric juice. This stable peptide has demonstrated remarkable resilience in laboratory conditions, maintaining structural integrity across a wide pH range—a property that has made it particularly valuable for in vitro and in vivo research protocols. Published studies indicate that BPC-157 may influence multiple biological pathways relevant to tissue regeneration research. Laboratory investigations have explored its potential interactions with nitric oxide systems, growth factor expression, and angiogenic processes. Researchers have documented its use in studies examining connective tissue, muscle fiber recovery, and gastrointestinal integrity in animal models. Research Applications Tissue repair mechanisms Wound healing pathways Musculoskeletal research Gastrointestinal studies Tendon and ligament investigations This product is intended solely for laboratory research and scientific investigation.

BPC-157 (Body Protection Compound) is extensively studied for: - Accelerated wound healing and tissue repair - Tendon, ligament, and muscle healing - Gastrointestinal protection and healing - Neuroprotective effects - Anti-inflammatory properties - Angiogenesis promotion - Bone and joint healing

BPC-157 works through multiple pathways: 1. Upregulation of growth factor receptors 2. Increased VEGF expression promoting angiogenesis 3. FAK-paxillin pathway activation 4. Nitric oxide system modulation 5. Serotonin system interaction 6. Dopamine system protection 7. Prostaglandin system regulation

Accelerated healing of wounds, tendons, ligaments, and muscles Gastrointestinal tract protection and repair Reduced inflammation Enhanced angiogenesis (new blood vessel formation) Neuroprotective effects Joint and bone healing support Organ protection (liver, heart, brain) Pain reduction

Research dosages typically range: - Standard dose: 250-500mcg daily - Loading dose: 500-1000mcg daily for 2-4 weeks - Maintenance: 250mcg daily or every other day - Administration: Subcutaneous injection near injury site or abdomen - Cycle length: 4-12 weeks typical

Generally well-tolerated with minimal side effects: - Mild fatigue - Temporary nausea (rare) - Slight dizziness - Injection site irritation - No significant systemic side effects reported in research